MX2012002967A - Derivados de isoxazolidina. - Google Patents

Derivados de isoxazolidina.

Info

Publication number
MX2012002967A
MX2012002967A MX2012002967A MX2012002967A MX2012002967A MX 2012002967 A MX2012002967 A MX 2012002967A MX 2012002967 A MX2012002967 A MX 2012002967A MX 2012002967 A MX2012002967 A MX 2012002967A MX 2012002967 A MX2012002967 A MX 2012002967A
Authority
MX
Mexico
Prior art keywords
inflammatory agents
pregnane derivatives
isoxazolidine ring
derivatives condensed
substituted isoxazolidine
Prior art date
Application number
MX2012002967A
Other languages
English (en)
Inventor
Elisabetta Armani
Ilaria Peretto
Eleonora Ghidini
Andrea Virdis
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41666572&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2012002967(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of MX2012002967A publication Critical patent/MX2012002967A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036—Nitrogen-containing hetero ring
    • C07J71/0057—Nitrogen and oxygen
    • C07J71/0068—Nitrogen and oxygen at position 16(17)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Steroid Compounds (AREA)

Abstract

Se describen novedosos compuestos anti-inflamatorios y antialérgicos de la serie de los glucocorticosteroides, métodos para preparar los compuestos, composiciones farmacéuticas que comprenden a los mismos y combinaciones y usos terapéuticos de los mismos. Más particularmente, la invención se relaciona con glucocorticosteroides que son derivados de isoxazolidina.
MX2012002967A 2009-09-11 2010-09-01 Derivados de isoxazolidina. MX2012002967A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09011665 2009-09-11
PCT/EP2010/005366 WO2011029547A2 (en) 2009-09-11 2010-09-01 Pregnane derivatives condensed in the 16, 17 position with an n-substituted isoxazolidine ring as anti-inflammatory agents

Publications (1)

Publication Number Publication Date
MX2012002967A true MX2012002967A (es) 2012-04-30

Family

ID=41666572

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012002967A MX2012002967A (es) 2009-09-11 2010-09-01 Derivados de isoxazolidina.

Country Status (28)

Country Link
US (1) US8637662B2 (es)
EP (2) EP2993178A1 (es)
JP (1) JP2013504524A (es)
KR (1) KR101451486B1 (es)
CN (2) CN102482318B (es)
AR (2) AR078164A1 (es)
AU (1) AU2010294598B2 (es)
BR (1) BR112012005503B1 (es)
CA (1) CA2773594C (es)
CL (1) CL2012000450A1 (es)
CO (1) CO6511204A2 (es)
EA (1) EA025191B1 (es)
GE (1) GEP20146135B (es)
HK (2) HK1166085A1 (es)
IL (1) IL218539A (es)
JO (1) JO3760B1 (es)
MA (1) MA33561B1 (es)
ME (1) ME01331B (es)
MX (1) MX2012002967A (es)
MY (1) MY164842A (es)
NZ (1) NZ598662A (es)
PE (1) PE20120894A1 (es)
SG (2) SG179055A1 (es)
TN (1) TN2012000077A1 (es)
TW (1) TWI494318B (es)
UA (1) UA108858C2 (es)
WO (1) WO2011029547A2 (es)
ZA (1) ZA201201705B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2993178A1 (en) * 2009-09-11 2016-03-09 CHIESI FARMACEUTICI S.p.A. Glucocorticoid condensed in position 16,17 with an isoxazolidine group
TW201139369A (en) * 2010-02-05 2011-11-16 Chiesi Farma Spa Pyrrolidine derivatives
MX345400B (es) 2011-03-15 2017-01-30 Chiesi Farm Spa Derivados de isoxazolidina.
EP2686333A2 (en) 2011-03-15 2014-01-22 Chiesi Farmaceutici S.p.A. Isoxazolidine derivatives
CA2843782A1 (en) * 2011-08-01 2013-02-07 Chiesi Farmaceutici S.P.A. Anti-inflammatory steroids condensed in position 16,17 with pyrrolidine ring
US9155747B2 (en) * 2012-09-13 2015-10-13 Chiesi Farmaceutici S.P.A. Isoxazolidine derivatives
RU2688191C2 (ru) 2014-05-12 2019-05-21 ВЕРОНА ФАРМА ПиэЛСи Новое лечение
ES2802202T3 (es) 2014-09-03 2021-01-15 Rhizen Pharmaceuticals S A Método de tratamiento y composiciones que comprenden un inhibidor dual de la quinasa PI3K delta-gama y un corticoesteroide
CN104262440B (zh) * 2014-09-10 2016-08-17 江西赣亮医药原料有限公司 一种16ɑ-羟基***龙的制备方法
CN109206471B (zh) * 2017-06-30 2022-07-12 天津药业研究院股份有限公司 一种哈西奈德的制备方法
CN109575096B (zh) * 2019-01-20 2021-01-01 湖南科瑞生物制药股份有限公司 一种制备16a-羟基***龙产品的新方法
CN112142820A (zh) * 2019-06-29 2020-12-29 天津药业研究院股份有限公司 曲安奈德的合成方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1131213B (de) * 1958-06-13 1962-06-14 Syntex Sa Verfahren zur Herstellung neuer Pregnanverbindungen
US3048581A (en) * 1960-04-25 1962-08-07 Olin Mathieson Acetals and ketals of 16, 17-dihydroxy steroids
BR6678983D0 (pt) * 1965-05-04 1973-09-18 Merck & Co Inc Processo para preparar 21-fosfato esteroides
SE307576B (es) * 1966-01-27 1969-01-13 Bofors Ab
IL31997A (en) * 1968-05-03 1974-03-14 Lepetit Spa Process for the preparation of pregnano(17alpha,16alpha-d)oxazolines and 16alpha,21-dihydroxy-17alpha-aminopregnanes
GB1302572A (es) * 1969-05-05 1973-01-10
US3996359A (en) * 1972-05-19 1976-12-07 Ab Bofors Novel stereoisomeric component A of stereoisomeric mixtures of 2'-unsymmetrical 16,17-methylenedioxy steroid 21-acylates, compositions thereof, and method of treating therewith
SE378110B (es) * 1972-05-19 1975-08-18 Bofors Ab
US4018774A (en) * 1976-02-13 1977-04-19 E. R. Squibb & Sons, Inc. Steroidal [16α,17-d]isoxazolidines
DE3133631A1 (de) * 1981-08-21 1983-03-03 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue kortikoide ihre herstellung und verwendung
US5200518A (en) * 1991-02-21 1993-04-06 Kangweon National University Anti-inflammatory carboxycyclic acetal pregnane derivatives
JP2749778B2 (ja) * 1994-09-05 1998-05-13 日清食品株式会社 トリアムシノロン誘導体
WO2005028495A1 (en) * 2003-09-24 2005-03-31 Glaxo Group Limited Anti-inflammatory glucocorticoids
GB0415747D0 (en) * 2004-07-14 2004-08-18 Novartis Ag Organic compounds
RU2008100237A (ru) * 2005-06-14 2009-07-20 Джилид Сайэнс, Инк. (US) ОБЩИЕ ПРОЛЕКАРСТВЕННЫЕ ФОРМЫ СТЕРОИДОВ И β-АГОНИСТОВ (ВАРИАНТЫ), ВКЛЮЧАЮЩИЙ ИХ АЭРОЗОЛЬНЫЙ СОСТАВ (ВАРИАНТЫ) И СПОСОБ ПРЕДОТВРАЩЕНИЯ И/ИЛИ ЛЕЧЕНИЯ ЛЕГОЧНЫХ ВОСПАЛЕНИЙ И/ИЛИ БРОНХОСТЕНОЗА С ИХ ПОМОЩЬЮ
TW200944540A (en) * 2007-12-21 2009-11-01 Schering Corp C20-C21 substituted glucocorticoid receptor agonists
US20110294766A1 (en) * 2008-02-27 2011-12-01 Astrazeneca Ab 16 Alpha, 17 Alpha-Acetal Glucocorticosteroidal Derivatives and their Use
EP2993178A1 (en) * 2009-09-11 2016-03-09 CHIESI FARMACEUTICI S.p.A. Glucocorticoid condensed in position 16,17 with an isoxazolidine group

Also Published As

Publication number Publication date
KR20120055651A (ko) 2012-05-31
US20110065678A1 (en) 2011-03-17
MA33561B1 (fr) 2012-09-01
CA2773594C (en) 2018-09-25
AR078164A1 (es) 2011-10-19
WO2011029547A2 (en) 2011-03-17
SG10201608490VA (en) 2016-11-29
TN2012000077A1 (en) 2013-09-19
IL218539A0 (en) 2012-05-31
EP2475676A2 (en) 2012-07-18
WO2011029547A8 (en) 2011-06-16
CN102482318A (zh) 2012-05-30
SG179055A1 (en) 2012-04-27
TW201114776A (en) 2011-05-01
AU2010294598A1 (en) 2012-04-05
CO6511204A2 (es) 2012-08-31
ME01331B (me) 2013-12-20
JP2013504524A (ja) 2013-02-07
GEP20146135B (en) 2014-08-11
EA201290091A1 (ru) 2012-12-28
NZ598662A (en) 2014-03-28
KR101451486B1 (ko) 2014-10-22
CN105175479A (zh) 2015-12-23
UA108858C2 (xx) 2015-06-25
CN102482318B (zh) 2015-11-25
CA2773594A1 (en) 2011-03-17
TWI494318B (zh) 2015-08-01
CN105175479B (zh) 2017-06-09
BR112012005503B1 (pt) 2021-10-13
US8637662B2 (en) 2014-01-28
BR112012005503A2 (pt) 2016-04-19
IL218539A (en) 2015-09-24
EP2475676B1 (en) 2020-05-27
AU2010294598B2 (en) 2016-09-01
HK1166085A1 (zh) 2012-10-19
HK1218759A1 (zh) 2017-03-10
EA025191B1 (ru) 2016-11-30
CL2012000450A1 (es) 2012-08-10
PE20120894A1 (es) 2012-08-13
ZA201201705B (en) 2013-05-29
JO3760B1 (ar) 2021-01-31
EP2993178A1 (en) 2016-03-09
MY164842A (en) 2018-01-30
WO2011029547A3 (en) 2011-08-18
AR118123A2 (es) 2021-09-22

Similar Documents

Publication Publication Date Title
TN2012000077A1 (en) Pregnane derivatives condensed in the 16, 17 position with an n-substituted isoxazolidine ring as anti-inflammatory agents
BR112019024747A2 (pt) formulações de dose fixa
EP2576578A4 (en) POLYMORPHES OF 2'-O-FUCOSYLLACTOSE AND MANUFACTURE THEREOF
TW201129565A (en) Tricyclic heterocyclic compounds, compositions and methods of use thereof
EA201500650A1 (ru) Фенилацетат l-орнитина и способы его получения
TN2013000321A1 (en) C-17 and c-3 modified triterpenoids with hiv maturation inhibitory activity
WO2012024620A3 (en) Autotaxin inhibitors and uses thereof
CL2008003480A1 (es) Compuestos derivados de amino-pirimidina, con propiedades inmunomoduladoras y que actuan a traves de tlr7; proceso para preparar los compuestos; compuestos intermediarios; composicion y combinacion farmaceutica que comprende a uno de los compuestos; y uso de los compuestos en la preparacion de medicamentos
TN2012000126A1 (en) Polycyclic compounds as lysophosphatidic acid receptor antagonists
BR112012013431A8 (pt) composto, composição farmacêutica e seu uso
UA109868C2 (ru) Соединения n-алкилтриазола как антагонисты лизофосфатидной кислоты (lpar)
AU2012253757A8 (en) Partially saturated tricyclic compounds and methods of making and using same
IN2014CN03307A (es)
BR112014027981A2 (pt) compostos do tipo fumagilol e métodos de produção e utilização dos mesmos
TN2013000313A1 (en) Isoxazolidine derivatives
MX2012000954A (es) Composicion far,aceutica topica que incuye la rel-n-[6-[(2r,6s)-2,6-dimetil-4-morfolinil]-3-piridinil]-2-metil- 4'-(trifluoro-metoxi)-[1,1'-bifenil]-3-carboxamida.
PH12015500534B1 (en) Isoxazolidine derivatives
CL2008002060A1 (es) Compuestos derivados de sulfonamida, inhibidores de la produccion de beta amiloide; metodo de preparacion; composicion farmaceutica; kit farmaceutico; y uso en el tratamiento de enfermedades tales como alzheimer, angiopatia amiloide, sindrome de down, entre otras.
WO2012123493A3 (en) Isoxazolidine derivatives
CR20110021A (es) Composiciones farmaceuticas basadas en antagonistas del receptor de quinina b2 y corticosteroides, y su uso
EA200900172A1 (ru) Фармацевтическая композиция для контрацепции
MX2013008536A (es) Triterpenoides c-17 y c-3 modificados con actividad inhibidora de la maduracion del virus de inmunodeficiencia humana.

Legal Events

Date Code Title Description
FG Grant or registration